ALX Oncology Holdings Inc.

NASDAQ:ALXO

0.8314 (USD) • At close March 13, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 00002.4800000000000000.5270.6551.2131.2561.2951.032
Kosten van de omzet 000.220.2140.2070.2090.5130.5180.41300.280.3760.2590.2620.1520.005000.4790.5961.1031.1421.1770.938
Brutowinst 00-0.22-0.2142.273-0.209-0.513-0.518-0.4130-0.28-0.376-0.259-0.262-0.152-0.005000.0480.0590.110.1140.1180.094
Brutowinstmarge 00000.917000000000000.09100.0910.090.0910.0910.0910.091
Onderzoek- en ontwikkelingskosten 23.53226.47134.65331.71741.78445.76629.48224.76325.19729.38226.74817.07320.89418.21411.2139.84912.1425.3287.6633.8286.7352.213.6283.733
Algemene en administratieve kosten 7.0816.0966.8726.0456.2397.5097.2957.447.0227.2997.0417.6747.5786.3625.0864.3595.6834.4813.1721.4731.1080.9380.6790.588
Verkoop- en marketingkosten 00-0.22-0.214-0.2070000000000000000000
Verkoop-, algemene en administratieve kosten 7.0816.0966.6525.8316.0327.5097.2957.447.0227.2997.0417.6747.5786.3625.0864.3595.6834.4813.1721.4731.1080.9380.6790.588
Overige kosten 00-0.008-0.014-0.029-0.0010.3240.095-0.233-0.009-0.007-0.0110.0160.0140.0280.0260.005-0.111-0.3050.007-0.001-0.0020-0.002
Bedrijfskosten 30.61332.56741.30537.54847.81653.27536.77732.20332.21936.68133.78924.74728.47224.57616.29914.20817.8259.80910.8355.3017.8433.1484.3074.321
Bedrijfsresultaat -30.613-32.567-41.525-37.762-48.023-53.275-36.777-32.203-32.219-36.681-33.789-24.747-28.472-24.576-16.299-14.208-17.825-9.809-10.787-5.242-7.733-3.034-4.189-4.227
Bedrijfsresultaat ratio 0000-19.36400000000000-15,080,372.250-20.469-8.003-6.375-2.416-3.235-4.096
Totaal overige inkomsten en kosten netto 1.451.862.1262.1812.5512.2852.6182.0191.5741.3610.8690.2140.0130.010.0250.023-0.767-0.337-0.524-0.208-0.022-0.0020-0.002
Inkomen voor belasting -29.163-30.707-39.399-35.581-45.472-50.99-34.159-30.184-30.645-35.32-32.92-24.533-28.459-24.566-16.274-14.185-18.592-10.146-11.311-5.45-7.755-3.036-4.189-4.229
Inkomen voor belasting ratio 0000-18.33500000000000-15,729,272.420-21.463-8.321-6.393-2.417-3.235-4.098
Belastingkosten 0000.1711.145-0.2090.696-1.6320.064-1.37-0.869-0.214-0.0210.0180.0310.0290.1820.0350.020.0040.0090.0080.0080.009
Nettowinst -29.163-30.707-39.399-35.581-45.472-50.99-34.159-28.552-30.709-35.32-32.051-24.319-28.438-24.566-16.274-14.185-18.774-10.181-11.331-5.454-7.764-3.044-4.197-4.238
Nettowinstmarge 0000-18.33500000000000-15,883,248.7310-21.501-8.327-6.401-2.424-3.241-4.107
WPA (Winst Per Aandeel) -0.55-0.58-0.76-0.71-0.93-1.24-0.84-0.7-0.75-0.87-0.79-0.6-0.7-0.61-0.4-0.35-0.5-0.34-0.33-0.16-0.35-0.14-0.19-0.19
Verwaterde WPA -0.55-0.58-0.76-0.71-0.93-1.24-0.84-0.7-0.75-0.87-0.79-0.6-0.7-0.61-0.4-0.35-0.5-0.34-0.33-0.16-0.35-0.14-0.19-0.19
EBITDA -28.522-30.037-38.75-34.94-44.85-50.39-33.274-29.279-32.114-34.923-32.64-24.157-28.422-24.556-16.265-14.203-18.436-9.915-11.013-5.122-7.622-2.925-4.08-4.132
EBITDA ratio 0000-19.28100000000000-15,076,142.1320-20.898-7.82-6.284-2.329-3.151-4.004